Yubo International Biotech annual revenue
2011
2012
2014
2015
2016
2017
2018
2019
2020
2020
2021
2022
2023
2024
2025
Yubo International Biotech Revenue Growth & History (YBGJ)
Yubo International Biotech reported $12,353 in revenue for fiscal 2025, an increase of 255.99% from the previous fiscal year.
View full Yubo International Biotech company overviewYubo International Biotech annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $12,353 | $8,883 | +255.99% |
| 2024 | 2024-12-31 | $3,470 | −$601,206 | −99.43% |
| 2023 | 2023-12-31 | $604,676 | $500,393 | +479.84% |
| 2022 | 2022-12-31 | $104,283 | −$1.1M | −91.62% |
| 2021 | 2021-12-31 | $1.2M | $1.2M | — |
| 2020 · Dec 31 | 2020-12-31 | $0 | — | — |
| 2020 · Feb 29 | 2020-02-29 | $0 | $0 | — |
| 2019 | 2019-02-28 | $0 | $0 | — |
| 2018 | 2018-02-28 | $0 | $0 | — |
| 2017 | 2017-02-28 | $0 | $0 | — |
| 2016 | 2016-02-29 | $0 | $0 | — |
| 2015 | 2015-02-28 | $0 | $0 | — |
| 2014 | 2014-02-28 | $0 | — | — |
| 2012 | 2012-02-29 | $0 | $0 | — |
| 2011 | 2011-02-28 | $0 | — | — |
Yubo International Biotech quarterly revenue
Q3.11
Q1.12
Q3.12
Q1.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | $0 | — |
| Q1 2026 | 2026-03-31 | $0 | $0 | — |
| Q4 2025 | 2025-12-31 | $12,353 | $12,371 | +68727.78% |
| Q3 2025 | 2025-09-30 | $0 | $0 | — |
| Q2 2025 | 2025-06-30 | $0 | $0 | — |
| Q1 2025 | 2025-03-31 | $0 | −$3,488 | −100.00% |
| Q4 2024 | 2024-12-31 | −$18 | −$18,139 | −100.10% |
| Q3 2024 | 2024-09-30 | $0 | −$428,510 | −100.00% |
| Q2 2024 | 2024-06-30 | $0 | −$1,430 | −100.00% |
| Q1 2024 | 2024-03-31 | $3,488 | −$153,127 | −97.77% |
| Q4 2023 | 2023-12-31 | $18,121 | −$48,399 | −72.76% |
| Q3 2023 | 2023-09-30 | $428,510 | $413,930 | +2839.03% |
| Q2 2023 | 2023-06-30 | $1,430 | −$6,540 | −82.06% |
| Q1 2023 | 2023-03-31 | $156,615 | $141,402 | +929.48% |
| Q4 2022 | 2022-12-31 | $66,520 | — | — |
| Q3 2022 | 2022-09-30 | $14,580 | −$83,723 | −85.17% |
| Q2 2022 | 2022-06-30 | $7,970 | — | — |
| Q1 2022 | 2022-03-31 | $15,213 | — | — |
| Q3 2021 · Sep 30 | 2021-09-30 | $98,303 | — | — |
| Q3 2021 · Nov 30 | 2020-11-30 | $0 | $0 | — |
| Q2 2021 · Aug 31 | 2020-08-31 | $0 | $0 | — |
| Q1 2021 · May 31 | 2020-05-31 | $0 | $0 | — |
| Q4 2020 | 2020-02-29 | $0 | $0 | — |
| Q3 2020 | 2019-11-30 | $0 | $0 | — |
| Q2 2020 | 2019-08-31 | $0 | $0 | — |
| Q1 2020 · May 31 | 2019-05-31 | $0 | $0 | — |
| Q4 2019 | 2019-02-28 | $0 | $0 | — |
| Q3 2019 | 2018-11-30 | $0 | $0 | — |
| Q2 2019 | 2018-08-31 | $0 | $0 | — |
| Q1 2019 | 2018-05-31 | $0 | $0 | — |
| Q4 2018 | 2018-02-28 | $0 | $0 | — |
| Q3 2018 | 2017-11-30 | $0 | $0 | — |
| Q2 2018 | 2017-08-31 | $0 | $0 | — |
| Q1 2018 | 2017-05-31 | $0 | $0 | — |
| Q4 2017 | 2017-02-28 | $0 | $0 | — |
| Q3 2017 | 2016-11-30 | $0 | $0 | — |
| Q2 2017 | 2016-08-31 | $0 | $0 | — |
| Q1 2017 | 2016-05-31 | $0 | $0 | — |
| Q4 2016 | 2016-02-29 | $0 | $0 | — |
| Q3 2016 | 2015-11-30 | $0 | $0 | — |
| Q2 2016 | 2015-08-31 | $0 | $0 | — |
| Q1 2016 | 2015-05-31 | $0 | $0 | — |
| Q4 2015 | 2015-02-28 | $0 | $0 | — |
| Q3 2015 | 2014-11-30 | $0 | $0 | — |
| Q2 2015 | 2014-08-31 | $0 | $0 | — |
| Q1 2015 | 2014-05-31 | $0 | $0 | — |
| Q4 2014 | 2014-02-28 | $0 | — | — |
| Q3 2014 | 2013-11-30 | $0 | — | — |
| Q2 2014 | 2013-08-31 | $0 | — | — |
| Q1 2014 | 2013-05-31 | $0 | $0 | — |
| Q1 2013 | 2012-05-31 | $0 | $0 | — |
| Q3 2012 | 2011-11-30 | $0 | $0 | — |
| Q1 2012 | 2011-05-31 | $0 | — | — |
| Q3 2011 | 2010-11-30 | $0 | — | — |
Yubo International Biotech revenue growth trends
Yubo International Biotech's latest reported quarter, Q2 2026, generated $0 in revenue.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Yubo International Biotech source filings ↗